«
We used human skin cells that we obtained from patients affected with ALS and converted them into neurons via a technology called induced pluripotent stem cell production,» she explains.
To make the HSCs, the Harvard group
used human skin cells to create induced pluripotent stem cells (iPSCs), adult cells researchers genetically reprogram to an embryonic - stem - cell state, where they can grow into any kind of cell.
Not exact matches
In a rare appearance Dr. Chandan Sen, Director, OSU Center for Regenerative Medicine &
Cell - Based Therapies will explain how this breakthrough came about and how the technology is leading to other medical discoveries and how the principle can be
used to generate any tissue out of
skin or fat which is abundant in
human body.
Unlike the controversial method of tissue harvesting that requires some
human embryos to be destroyed, the new cloning technique can
use a patient's own
skin cells — combined with an unfertilized
human egg — to create tissue with a DNA match.
Scientists looking for new methods to make
human tissue have successfully
used cloning technology to create embryonic stem
cells from
skin cells.
Using viral gene insertion and regulatory proteins, researchers turned adult
human skin cells directly into adult
human blood
cells, without first returning them to a fully pluripotent state.
Anand and his colleague Susan McKay started with
human skin cells, which they turned into induced pluripotent stem
cells (iPSCs)
using a tried - and - tested method.
Using a mathematical model known as the Ising model, invented to describe phase transitions in statistical physics, such as how a substance changes from liquid to gas, the Johns Hopkins researchers calculated the probability distribution of methylation along the genome in several different
human cell types, including normal and cancerous colon, lung and liver
cells, as well as brain,
skin, blood and embryonic stem
cells.
«Our results demonstrate for the first time that
human adult
skin cells can be
used to efficiently and rapidly generate functional pancreatic
cells that behave similar to
human beta
cells,» says Matthias Hebrok, PhD, director of the Diabetes Center at UCSF and a co-senior author on the study.
In May 2013, Mitalipov was the first scientist in the world to demonstrate the successful
use of somatic
cell nuclear transfer, or SCNT, to produce
human embryonic stem
cells from an individual's
skin cell.
Human epidermal equivalents representing different types of
skin could also be grown, depending on the source of the stem
cells used, and could thus be tailored to study a range of
skin conditions and sensitivities in different populations.»
A California company reported today that it has, for the first time, cloned
human embryos
using DNA from adult
skin cells.
The scientist tested their set - up
using frozen
human skin cells, segments of pig heart tissue, and sections of pig arteries in volumes almost 20 times larger than previously attempted samples.
One
uses primary hepatocytes obtained from livers donated for transplant; the second
uses stem
cells derived from
human skin samples and guided into hepatocyte - like
cells, Bhatia says.
The study carried out at the University of Eastern Finland
used the induced pluripotent stem
cell technology, which enables the generation of pluripotent stem
cells from
human skin fibroblasts.
For the new study, the team
used a
cell - reprogramming technique (similar to those
used to reprogram
skin cells into stem
cells) to generate
human DRG - type sensory neurons from ordinary
skin cells called fibroblasts.
«It appeared we wouldn't be able to create enough
human OPCs for widespread therapeutic
use, so we began to wonder if we could create them directly from
skin cells.»
Using a process called cellular reprogramming, the researchers take a patient's
skin cells, convert them into so - called induced pluripotent stem (iPS)
cells, which can differentiate into all the
cells within the
human body.
Both teams successfully
used these to reprogramme
skin cells in a lab dish into
cells resembling embryonic stem
cells, which have the ability to turn into any tissue of the
human body.
At the time, his varied interests — in the
use of
skin cell culture to treat burns, in
human tissue cultures, and in biopharmaceutical production — led him to do his final year, 6 - month project on culture in a bioreactor.
Humans have many
cell types - nerve
cells, blood
cells,
skin cells, to name a few - and while each
cell contains the same genetic instructions, different parts of the genetic information are
used to produce proteins in each type of
cell.
Gladstone scientist Dr. Sheng Ding has exposed more chameleon - like qualities of the
human skin cell,
using chemical cocktails to turn
skin cells into fully functional brain, heart, liver, and insulin - producing pancreas
cells.
The advantages of this approach began to emerge in 2011, when Dr. Ding announced that he had
used his «chemical reprogramming» method to convert
human skin cells into brain
cells.
Recently, his lab
used induced pluripotent stem (iPS)
cells — adult
cells made to act like embryonic stem
cells — made from
skin cells of patients carrying apoE4, or other mutations related to Alzheimer's, to study their effects on the development, survival, and degeneration of
human neurons.
Globs of
human fat removed during liposuction conceal versatile
cells that are more quickly and easily coaxed to become induced pluripotent stem
cells, or iPS
cells, than are the
skin cells most often
used by researchers, according to a new study from Stanford's School of Medicine.
Strengthening the link between Zika virus and microcephaly, scientists at UC San Francisco have discovered that a protein the virus
uses to infect
skin cells and cause a rash is present also in stem
cells of the developing
human brain and retina.
Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed
cells from
human skin into
cells that produce insulin, the hormone
used to treat diabetes.
Yet this study brings us tantalisingly close to
using skin cells to grow many different types of
human tissues.
Yamanaka's group
used human adult
skin cells and induced them to become iPS
cells by having them produce the same protein factors that the mouse iPS
cells had.
Human skin cells have also been directly converted into neurons that can be
used to study and find treatments for diseases in the brain, as well as liver
cells and insulin - producing
cells of the pancreas.
In the Science study, led by first author Nan Cao, PhD, a postdoctoral fellow in Ding's lab, the researchers
used a cocktail of nine chemicals to change
human skin cells into beating heart
cells.
In the Science study, Ding's team
used trial and error to find a combination of chemicals that could induce
human skin cells to turn into multipotent stem
cells, and then into cardiomyocytes.
Using Gladstone's unique expertise, the scientists then
used induced pluripotent stem
cells (iPSCs), generated from adult
human skin cells, to create a type of beating heart
cell known as cardiomyocytes.
Only a year after he produced the first iPS
cells from adult mouse
skin cells, Yamanaka generated iPS
cells from adult
human skin cells, employing
human versions of the same four genes that he had
used in the mouse work.
Several trials
using human cells have shown it to have protective effects on the
skin.
Our writer investigates the benefits of
using skin care products that contain plant - derived stem
cells — and non-embryonic
human cells extracted from consenting egg donors (seriously).
Currently, her lab is focused on finding drugs suitable for eliminating mammary cancer and ocular herpevirus infections in small companion animals, and evaluating the effectiveness of stem
cell therapies for treating
skin wounds in horses — all of which may also be
used in
humans and other animals.